Genzyme wraps up Seprafilm data

Genzyme Corp. on Friday presented part two of its clinical package for Seprafilm, its bioresorbable hyaluronic acid-based membrane to prevent surgical adhesions. In October, GENZ presented data showing that Seprafilm prevented adhesions in abdominal surgery.

As presented at the Brussels meeting of the European Society for Gynaecological Endoscopy, use of Seprafilm resulted in 37 percent fewer adhesions to the uterus...